Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 6Thoracic 1Lymphoid 1Head & Neck 1Dermatologic 1CNS 1

Conditions

Neoplasms 1Melanoma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell, Cutaneous 1Lymphoma 1Lung Neoplasms 1Head and Neck Neoplasms 1Colonic Neoplasms 1

Interventions

pembrolizumab 6cemiplimab 3Cyclophosphamide 3temsirolimus 2palbociclib 2cediranib 2Therapeutics 2Radiotherapy 2Radiosurgery 2Psychiatric Rehabilitation 2Paclitaxel 2Oxaliplatin 2Nivolumab 2Methods 2Magnetic Resonance Spectroscopy 2Leucovorin 2Gemcitabine 2Fluorouracil 2Drug Therapy 2Docetaxel 2Cisplatin 2Capecitabine 2Biological Therapy 22,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 2ulixertinib 1trastuzumab biosimilar HLX02 1trametinib 1tanespimycin 1sonidegib 1sargramostim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colonic Neoplasms × Magnetic Resonance Imaging × Dermatologic × Clear all
NCT01557881 2020-02-24

Positron Emission Tomography/Magnetic Resonance Imaging in Patients

Case Comprehensive Cancer Center

Phase NA Terminated
98 enrolled 5 charts
DermatologicGastrointestinalHead & NeckLymphoidThoracic

Colonic Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Lymphoma, Melanoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡